(Q52662066)
Statements
Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease (English)
Christopher P Cannon
Jamie P Dwyer
Helen M Colhoun
Daniel J Rader
Michael J Louie
Andrew Koren
scientific article published on 8 March 2018